Ir para o conteúdo principal

Grafa News and Videos — Page 110

Destaques de Grafa

Grafa
Health

GRAIL shares surge after FDA reviewers raise no major concerns on Galleri cancer test

GRAIL (NASDAQ:GRAL) shares rose sharply after U.S. Food and Drug Administration staff reviewers reported no major concerns regarding the safety and analytical performance of the company’s Galleri blood test designed to detect multiple cancers.

Leia mais: GRAIL shares surge after FDA reviewers raise no major concerns on Galleri cancer test

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas